Delineation of the clinical profile of CNOT2 haploinsufficiency and overview of the IDNADFS phenotype.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
02 2023
Historique:
revised: 06 10 2022
received: 19 07 2022
accepted: 08 10 2022
pubmed: 13 10 2022
medline: 7 1 2023
entrez: 12 10 2022
Statut: ppublish

Résumé

CNOT2 haploinsufficiency underlies a rare neurodevelopmental disorder named Intellectual Developmental disorder with NAsal speech, Dysmorphic Facies, and variable Skeletal anomalies (IDNADFS, OMIM 618608). The condition clinically overlaps with chromosome 12q15 deletion syndrome, suggesting a major contribution of CNOT2 haploinsufficiency to the latter. CNOT2 is a member of the CCR4-NOT complex, which is a master regulator of multiple cellular processes, including gene expression, RNA deadenylation, and protein ubiquitination. To date, less than 20 pathogenic 12q15 microdeletions encompassing CNOT2, together with a single truncating variant of the gene, and two large intragenic deletions have been reported. Due to the small number of affected subjects described so far, the clinical profile of IDNADFS has not been fully delineated. Here we report five unrelated individuals, three of which carrying de novo intragenic CNOT2 variants, one presenting with a multiexon intragenic deletion, and an additional case of 12q15 microdeletion syndrome. Finally, we assess the features of IDNADFS by reviewing published and present affected individuals and reevaluate the clinical phenotype of this neurodevelopmental disorder.

Identifiants

pubmed: 36224108
doi: 10.1111/cge.14247
pmc: PMC9939052
mid: NIHMS1865454
doi:

Substances chimiques

CNOT2 protein, human 0
Repressor Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

156-166

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS106298
Pays : United States

Informations de copyright

© 2022 The Authors. Clinical Genetics published by John Wiley & Sons Ltd.

Références

Am J Med Genet A. 2012 Feb;158A(2):333-9
pubmed: 22247066
Hum Mutat. 2013 Sep;34(9):E2393-402
pubmed: 23843252
Nat Struct Mol Biol. 2013 Nov;20(11):1289-97
pubmed: 24121232
Am J Med Genet A. 2008 Jan 1;146A(1):93-6
pubmed: 18076123
Am J Med Genet A. 2019 Apr;179(4):659-662
pubmed: 30768759
Hum Mutat. 2019 Aug;40(8):1030-1038
pubmed: 31116477
EMBO J. 2002 Feb 1;21(3):355-64
pubmed: 11823428
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nat Struct Mol Biol. 2005 Dec;12(12):1054-63
pubmed: 16284618
Am J Med Genet A. 2019 Dec;179(12):2506-2509
pubmed: 31512373
Nat Genet. 2014 Mar;46(3):310-5
pubmed: 24487276
PLoS One. 2014 Jan 17;9(1):e86218
pubmed: 24465968
Genes (Basel). 2021 Jun 30;12(7):
pubmed: 34208845
Clin Genet. 2023 Feb;103(2):156-166
pubmed: 36224108
Eur J Med Genet. 2017 Apr;60(4):220-223
pubmed: 28159701
Stem Cells. 2012 May;30(5):910-22
pubmed: 22367759
Eur J Hum Genet. 2011 Oct;19(10):1032-7
pubmed: 21505450
Nucleic Acids Res. 2000 Feb 1;28(3):809-17
pubmed: 10637334
Adv Sci (Weinh). 2021 Mar 16;8(10):2003636
pubmed: 34026442
Genes Cells. 2011 Apr;16(4):368-79
pubmed: 21299754
Am J Med Genet A. 2019 Aug;179(8):1615-1621
pubmed: 31145527
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
RNA Biol. 2013 Feb;10(2):267-76
pubmed: 23232451
Am J Med Genet A. 2021 Aug;185(8):2602-2606
pubmed: 34018673
Hum Mutat. 2015 Oct;36(10):928-30
pubmed: 26220891
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
RNA Biol. 2020 Mar;17(3):403-416
pubmed: 31924127
Am J Hum Genet. 2020 Jul 2;107(1):164-172
pubmed: 32553196
Nat Commun. 2019 Jul 18;10(1):3173
pubmed: 31320642
Nat Genet. 2016 Dec;48(12):1581-1586
pubmed: 27776117
Front Genet. 2014 Aug 21;5:286
pubmed: 25191340

Auteurs

Marcello Niceta (M)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Department of Pediatrics, Sapienza University, Rome, Italy.

Simone Pizzi (S)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Francesca Inzana (F)

Genetic Counseling Service, Regional Hospital of Bolzano, Bolzano, Italy.

Angela Peron (A)

Medical Genetics, ASST Santi Paolo e Carlo, Ospedale San Paolo, Milan, Italy.
Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.

Somayeh Bakhtiari (S)

Pediatric Movement Disorders Program, Division of Pediatric Neurology, Barrow Neurological Institute, Phoenix Children's Hospital, Phoenix, Arizona, USA.
Departments of Child Health, Neurology, and Cellular and Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.

Mathilde Nizon (M)

CHU Nantes, Service de Génétique Médicale, L'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.

Jonathan Levy (J)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Cecilia Mancini (C)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Benjamin Cogné (B)

Laboratoire de Génétique Moléculaire, CHU de Nantes, Nantes, France.

Francesca Clementina Radio (FC)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Emanuele Agolini (E)

Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Dario Cocciadiferro (D)

Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Antonio Novelli (A)

Translational Cytogenomics Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Mustafa A Salih (MA)

Neurology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Department of Pediatrics, College of Medicine, Almughtaribeen University, Khartoum, Sudan.

Maria Paola Recalcati (MP)

Medical Cytogenetics Laboratory, Istituto Auxologico Italiano IRCCS, Cusano Milanino, Italy.

Rosangela Arancio (R)

Clinica Pediatrica, Ospedale San Paolo, ASST Santi Paolo Carlo, Milan, Italy.

Marianne Besnard (M)

Service de Néonatologie, Centre Hospitalier de Polynésie Française, Papeete, French Polynesia.

Anne-Claude Tabet (AC)

Human Genetics and Cognitive Functions, Institut Pasteur, UMR3571 CNRS, Université de Paris, Paris, France.
Cytogenetic Unit, Robert Debré Hospital, APHP, Paris, France.

Michael C Kruer (MC)

Departments of Child Health, Neurology, and Cellular and Molecular Medicine, and Program in Genetics, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.

Manuela Priolo (M)

UOSD Genetica Medica, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli", Reggio Calabria, Italy.

Bruno Dallapiccola (B)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Marco Tartaglia (M)

Genetics and Rare Diseases, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH